Amalgamated Bank’s Procept Biorobotics PRCT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-1,675
Closed -$53K 2522
2025
Q4
$53K Buy
1,675
+132
+9% +$4.38K ﹤0.01% 1825
2025
Q3
$55K Hold
1,543
﹤0.01% 1817
2025
Q2
$89K Hold
1,543
﹤0.01% 1718
2025
Q1
$90K Buy
1,543
+126
+9% +$8.6K ﹤0.01% 1694
2024
Q4
$114K Hold
1,417
﹤0.01% 1675
2024
Q3
$114K Hold
1,417
﹤0.01% 1687
2024
Q2
$87K Buy
1,417
+40
+3% +$2.38K ﹤0.01% 1739
2024
Q1
$68K Sell
1,377
-4,427
-76% -$211K ﹤0.01% 1798
2023
Q4
$243K Buy
5,804
+316
+6% +$10.8K ﹤0.01% 1736
2023
Q3
$180K Buy
5,488
+442
+9% +$15.1K ﹤0.01% 1824
2023
Q2
$178K Buy
5,046
+1,444
+40% +$47.7K ﹤0.01% 1866
2023
Q1
$102K Sell
3,602
-604
-14% -$21.3K ﹤0.01% 2048
2022
Q4
$175K Buy
4,206
+97
+2% +$4.17K ﹤0.01% 1911
2022
Q3
$170K Buy
4,109
+63
+2% +$2.51K ﹤0.01% 1910
2022
Q2
$132K Buy
4,046
+2,922
+260% +$106K ﹤0.01% 2059
2022
Q1
$39K Buy
+1,124
New +$27K ﹤0.01% 2585

Other funds holding PRCT

Amalgamated Bank's PRCT Position: Q1 2026 in Review

Amalgamated Bank sold out of Procept Biorobotics (PRCT) in Q1 2026, closing a stake of 1,675 shares — an estimated $53K sold.

Amalgamated Bank first reported a position in PRCT in Q1 2022 and held it in 16 quarters. The position peaked at $243K in Q4 2023. 256 funds tracked by Wall St. Rank hold PRCT as of Q1 2026.

  • Amalgamated Bank reported no remaining Procept Biorobotics position as of Q1 2026 after selling out during the quarter.
  • Amalgamated Bank sold 1,675 Procept Biorobotics shares in Q1 2026, an estimated $53K.
  • Amalgamated Bank first reported a position in Procept Biorobotics in Q1 2022 and held it in 16 quarters.
  • Amalgamated Bank's Procept Biorobotics position peaked at $243K in Q4 2023.
  • 256 funds tracked by Wall St. Rank held Procept Biorobotics as of Q1 2026.

Based on Amalgamated Bank's 13F filing for Q1 2026, filed 8 May 2026.